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Abstract
Background: It is generally recognized that existential concerns must be addressed to promote the dignity of
patients with advanced cancer. A number of interventions have been developed in this regard, such as dignity
therapy and other life review interventions (LRI). However, so far, none have focused on a positive approach or
evaluated its effects on dignity and personal growth. This study aims to explore the feasibility of Revie ⊕, a life
review intervention comprising a positive, patient-centered approach, and to determine potential changes of
patients’ sense of dignity, posttraumatic growth, and satisfaction with life.
Methods: A mixed method study will be performed, which includes specialized nurses and 40 patients with advanced
cancer in an ambulatory and in-patient setting of a Swiss university hospital. Quantitative methods involve a single
group, pre- and post-intervention, and outcome measurements include the Patient Dignity Inventory, the
Posttraumatic Growth Inventory, and the Satisfaction with Life Scale. Feasibility data relating to process, resource, and
scientific elements of the trial will also be collected. A semi-directed interview will be used to collect qualitative data
about the process and the participants’ experiences of the intervention. In this way, enhanced quantitative-qualitative
evidence can be drawn from outcome measures as well as individual, contextualized personal views, to help inform
researchers about the plausibility of this complex intervention before testing its effectiveness in a subsequent full trial.
Discussion: Patient dignity is a goal of quality end-of-life care. To our knowledge, this is the first trial to evaluate the
role of a life review intervention that is focused on personal growth and on changes relating to the experience of
having cancer.
This study will evaluate the feasibility of a novel intervention, Revie ⊕, which we hope will contribute to promote the
dignity, personal growth, and overall life satisfaction of patients with advanced cancer.
Trial registration: ISRCTN, ISRCTN12497093
Keywords: Advanced cancer, Palliative care, Life review intervention, Posttraumatic growth, Dignity, Satisfaction with
life, Mixed methods
* Correspondence: MariaGoreti.DaRochaRodrigues@unil.ch
1Institute of Higher Education and Research in Healthcare, University of
Lausanne and University Hospital of Lausanne, 10 Route de la Corniche, 1010
Lausanne, Switzerland
2School of Health Sciences, University of Applied Sciences and Arts Western
Switzerland, 47 Avenue de Champel, 1206 Genève, Switzerland
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Da Rocha Rodrigues et al. Pilot and Feasibility Studies  (2016) 2:63 
DOI 10.1186/s40814-016-0101-z
Background
Approximately 37,000 new cases of cancer occur annually
in Switzerland. Despite advancements in medical technol-
ogy, cancer remains the second leading cause of mortality
(about 16,000 individuals per year) in Switzerland [1].
Patients with advanced cancer often experience significant
levels of existential distress [2, 3]. According to Kissane
[4], existential distress represents a person’s distress when
facing his/her own mortality, which brings out feelings of
helplessness, lack of sense, discouragement, or remorse.
Existential suffering is one of the most exhausting condi-
tions at the end of life [5]. There is a paucity of interven-
tions focusing on relieving spiritual or existential concerns
[2]. However, it is recommended to consider the patients’
and families’ values and beliefs; to help patients and
families in sharing their emotions and time; and to
support patients and families in carrying out realistic
projects [6, 7]. Interventions that relieve existential
distress support patients’ dying with dignity [8, 9]. In end-
of-life care, dying with dignity constitutes an important
aim, but this concept has multiple meanings. Accord-
ing to Guo and Jacelon [10], dying with dignity
includes a dying process with minimal symptom
distress, being human and being self, achieving exist-
ential and spiritual goals, and maintaining meaningful
relationships with significant relatives.
Dignity at the end of life is a major concern of health
professionals in care of people with advanced cancer
[11]. Nurses are most in contact with patients facing
life-threatening disease and they play a specific role in
providing quality of life, supporting health and well-
being [12, 13].
Despite continued developments and improvements in
palliative care in Switzerland, nursing interventions
promoting patient dignity are still insufficiently available
in routine clinical practice. To date, little empirical
research has focused on interventions to address exist-
ential distress [2]. One way of addressing these needs
and enhancing dignity during the end of life is a thera-
peutic life review intervention (LRI) [14]. This set of
interventions consists of evoking memories, personal life
events, and accomplishments. It is a structured process
of reinterpreting life existence [15].
LRIs in palliative situations have been shown to
have positive effects on quality of life [16, 17], spirit-
ual well-being [18], depression [19, 20], and death-
related anxiety [21]. The main perceptions of patients
are reconsideration and acceptance of the uniqueness
of their lives, finding meaning, defining future pro-
jects, reconciliation with their past experiences [22],
and the satisfaction of leaving a personal legacy [23].
Change also occurs within the family in terms of
perception, satisfaction [23–25], communication, and
cohesion [26, 27].
Despite cancer being widely seen as an adverse event,
some cancer patients report having experienced a degree
of personal growth that caused them to change their
values and relationships in positive ways. Tedeschi and
Calhoun [28, 29] defined this phenomenon as posttrau-
matic growth (PTG). It refers to the positive psycho-
logical change experienced as a result of struggles with
highly challenging life circumstances. In the context of
experiencing advanced cancer, PTG is documented.
Changes can occur through the intensification of human
relationships, a better outlook on life [30], greater reli-
gious satisfaction, increased compassion, and concern
for others [31]. The main positive outcomes of PTG are
decreased psychological distress [32] and depression [33,
34], as well as enhanced levels of general [31, 35] and
spiritual well-being [33].
While some LRIs have already been shown to have a
benefit at an existential level among individuals with ad-
vanced cancer, none, to our knowledge, are relying on
an approach centered on personal development, al-
though it has been shown that PTG can have a positive
influence on the well-being of patients with advanced
cancer [8]. Moreover, this type of intervention has not
yet been tested in the context of specific conditions and
circumstances that may be encountered in Switzerland.
In our current research, we propose to develop a spe-
cific LRI to promote existential needs in advanced can-
cer patients. We used the MRC framework for the
development of complex interventions [36] with the aim
to build on the World Health Organization’s (WHO)
recommendations for palliative care that emphasize the
importance of spiritual well-being. The intervention is
called Revie ⊕. It focuses on personal resources as well
as changes in relationships and values since the time of
diagnosis. The intervention is patient-centered and con-
sistent with the patient’s needs, values, and preferences.
Orienting the intervention to include a positive ap-
proach, namely to expand on the positive changes
brought on by the cancer experience, could contribute
to promote dignity, personal development, and a higher
degree of overall life satisfaction.
The purpose of the present study is to assess the feasi-
bility of the Revie ⊕ intervention and to evaluate poten-
tial changes in dignity, posttraumatic growth, and
satisfaction of life for patients with advanced cancer in
order to obtain data for a future effectiveness trial.
Methods/design
Aim/objectives
The overall aim of this study is to evaluate the feasibility
of Revie ⊕, a new LRI intervention aimed at patients
with advanced cancer within the ambulatory and in-
patient setting of a university hospital in the French-
speaking part of Switzerland, and to evaluate potential
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changes in dignity, posttraumatic growth, and satisfac-
tion with life.
Our primary objectives relate to the assessment of the
feasibility of the proposed recruitment strategies and
outcome assessment protocols:
1. Determine recruitment and retention rates and
identify best strategies for recruitment and retention
in this patient population (if 40 participants are
recruited over 12 months and with 80 % having
completed follow-up, the intervention is considered
feasible).
2. Determine the acceptability of the intervention for
the patients, in terms of:
(a)Engagement and compliance with the protocol
(b)Perceptions of barriers and facilitators
considering the sensitive and intimate topic and
the particular vulnerability of the population with
life-threatening disease
(c)The degree of satisfaction
(d)The perceived relevance of the intervention
3. Explore the acceptability for nurses delivering the
intervention in terms of fidelity (adherence
structured content), resources mobilized, perception
of barriers, and facilitators, considering the sensitive
and intimate discussion and practice change.
4. Estimate required sample size for a future larger
effectiveness trial.
The secondary objectives will be to assess the impact
of Revie ⊕ on the sense of dignity, posttraumatic
growth, and satisfaction with life for patients with
advanced cancer and to determine the most appropriate
outcome for a future larger trial.
Study design
We propose a pilot pre-post feasibility study using a
mixed method approach, i.e., an embedded concurrent
design with both quantitative and qualitative parts [37].
The quantitative part of the study consists of a single
pre-post-intervention group. The qualitative method is
nested within the predominant quantitative part and
includes semi-directed interviews with the patients to
obtain data on the intervention process and participants’
experiences and views.
Questionnaires and a focus group interview are used
to explore the health professionals’ acceptability.
An embedded concurrent design has been chosen
because the combination of quantitative and qualitative
methods will provide more information about the
barriers for participation, and an estimated response
rate. This study will also help us to better understand
the impact of the intervention on the participants (will-
ingness, unanticipated experiences during the trial,
resources that can facilitate to conduct the intervention,
the feedback of the patients and nurses about the inter-
vention delivery). The use of a mixed method is recom-
mended to improve interpretation of the results in
palliative care research [38, 39]. RCT may not be the
most appropriate design because of practical and ethical
obstacles. At this stage, we did not opt for a control
group as we did not intend to measure effectiveness in
the first place. Our main purpose was to develop a
theory-based intervention, determine the patients’ per-
ception and satisfaction with the intervention, explore
the patients’ adhesion to the intervention, determine the
appropriateness of the outcome measures, and identify
the adequacy of time, location, and process. In addition,
it was important to explore the emotions associated with
this intervention through the discussion of this intimate
and sensitive topic.
Study setting
A purposive sample of 40 patients with advanced cancer
will be recruited within the ambulatory and in-patient
setting of a university hospital in the French-speaking
part of Switzerland. As it is a pilot study, and the inter-
vention has not been tested previously, no formal sample
size calculation was conducted [40]. The sample size
was based on the recommendations by Hertzog [41]: a
sample of 20–40 persons is adequate for a pilot study
employing a single group to ultimately estimate the
sample size for a future trial.
This preliminary study reviews the recruitment; checks
the feasibility and the appropriateness of the instruments
used and the sample size required for a subsequent larger
study; and examines how the process (timing, duration,
etc.) could eventually be consolidated [36, 42]. Difficulties
of recruitment and retention are reported by similar
studies, particularly concerning advanced cancer patients
and studies over 12 months. However, considering that
approximately 800 persons consult annually in the two
participating settings and that 40 % of these persons are
potentially eligible for the study and estimating an 80 %
refusal, it seems feasible to recruit a total of 40 participants.
Inclusion criteria: adults (aged 18 years or older) with
advanced cancer (T3 or T4, or the presence of
metastases), with an adequate health status to
participate in the study, as determined by clinical
consensus between nurses and physicians, and who are
able to cognitively understand and consent to inclusion
in the study
Exclusion criteria: patients diagnosed with cognitive
disorders related to memory loss or disturbances of
speech that would not allow for a constructive
exchange, and people with insufficient command of the
French language to complete the study questionnaires
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Recruitment
Recruitment began in April 2015 and will take place
over a 12-month period. Information was given prior to
the commencement of the study to all the nurses, head
nurses, and oncologists of the services. A factsheet was
also made available to them. They all have a role to play
in informing patients about the study. Eligible patients
are invited by the nursing staff to participate in the
study. They are subsequently contacted by the re-
searcher(s), who provides an overview of the study and
presents the information letter and consent form to the
potential participant. A minimum of 24 h is given to the
participant to sign the consent form.
Regular meetings are planned between the research
team and the staff to identify and overcome any difficul-
ties encountered during this phase to enhance recruit-
ment. To date, 30 participants have been recruited.
Study overview
The study consists of three stages (Table 1): the pre-
intervention phase (T0), followed by the intervention
(T1), and, after its completion, the post-intervention phase
(T2). In light of recommendations by other investigators
who have implemented a similar intervention focused on
life review [16, 17], the time between T0 and T2 will be
limited to a maximum of 1 month. This timeframe takes
into account the rate of potential loss of participants due
to their lower general health status or as a result of patient
death, and the fact that the effects on the sense of dignity,
life satisfaction, and posttraumatic growth appear to occur
fairly soon after the intervention.
Description of the intervention
A brief life review intervention (Revie ⊕) was developed
based on a literature review and a theoretical model
focusing on a positive patient-centered approach. Revie
⊕ allows specialist nurses to talk about life events with
cancer patients, explore how the diagnosis has changed
their values and preferences, and discuss ultimate life
goals or projects. As an outcome of this LRI, a booklet
will be created by integrating the patient’s significant ele-
ments evoked during the intervention. The intervention
is delivered by eight nurses, all of whom are certified in
oncology care, have received specific theoretical and
evidence-based knowledge, and have the specific skills
needed to deliver a life review intervention. These nurses
are part of the staff. However, these nurses have time to
deliver the intervention. The intervention consists of
two sessions scheduled in mutual agreement between
nurse and patient, but above all favoring an appropriate
time for the patient. The face-to-face interview consti-
tutes a moment completely centered on the patient’s
experience. This face-to-face interview takes place in a
space reserved for this purpose. In order to conduct the
interview, the nurses follow a predefined guideline that
permits them to be in authentic presence with the par-
ticipants. The first session (T1) lasts for approximately
60 min and allows participants to share significant
events about their life history as well as supports
personal development by focusing on positive changes
that have occurred since the cancer diagnosis. Five do-
mains are addressed during this session: (1) a reflection
of the patient’s life story and specific significant events;
(2) a focus on the positive changes that have occurred
since the diagnosis; (3) an expression of the patient’s
values and vision of life (accentuating the strengths and
resources) and the patient’s relationship with others; (4)
a discussion of significant issues (i.e., what patients want
to communicate with their relatives, or determining the
project, which is most important to carry out); and (5) a
discussion of the patient’s deepest concerns and his/her
thoughts about death and dying. Throughout the inter-
vention, nurses value patients’ coping strategies, strengths,
and resources. The changes brought about by the patients’
experience of cancer on themselves and their life vision
and values as well as their relationship with others are at
the center of the intervention.
At the end of the interview, the participant is asked to
send pictures, poems, or drawings that he considers
important to the researcher. The tape recordings of the
session are transcribed by the research team. Thus, a
detailed account of the patients’ life events and experi-
ences are obtained. Based on these transcripts, a booklet
is created by the research team. The booklet consists of
about 12 pages in A5 format and covers four sections:
(1) my significant life events and the significant persons
in my life; (2) my experience of cancer; (3) my values/life
vision/changes; and (4) my project(s). Each booklet is
Table 1 Study procedure
T0: pre-test T1: intervention T2: post-test
Quantitative Session 1 Session 2 Quantitative Qualitative
Sociodemographic +
health data
PDIa, SWLSb, PTGIc
Encounter with trained nurse to
share life history + positive approach
Presenting and
finalizing the booklet
Acceptability questionnaire
PDP, SWLS, PTGI
Semi-structured interview
about the process
PDI Personal Dignity Inventory, SWLS Satisfaction with Life Scale, PTGI Posttraumatic Growth Inventory
aChochinov et al. [43]
bDiener et al. [50]
cTedeschi and Calhoun [46]
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personalized by highlighting its unique style with chosen
words (we strive to be as close as possible to patients’ words
and expressions). According to the patients’ wishes, texts,
poems, pictures, or citations are integrated into the booklet.
The second meeting (15–30 min duration) is arranged
to present, complete, if necessary change, and finalize
the booklet. Patients who did not send photos, poems,
or any other text before can include these at this
moment. Patients are fully integrated as main actors of
this process. If needed, another meeting is scheduled to
revise the booklet. The final version of the booklet is val-
idated by the patient before printing and delivering.
Data collection
A baseline assessment will take place at (T0), including
collection of the participants’ demographic data and data
on their religious/spiritual background, as well as med-
ical data such as tumor type, time since diagnosis, and
previous treatments.
Outcomes measures
The outcomes measures will be collected during two
stages (i.e., the pre-intervention T0 and the post-
intervention T2).
Dignity
The Patient Dignity Inventory (PDI) questionnaire
[43] was designed to assess dignity-related distress. It
consists of 25 items in three subcategories: illness-
related concerns, a dignity conserving repertoire, and
a social dignity inventory. The items are rated on a
five-point Likert scale ranging from 1 (“not a prob-
lem”) to 5 (“an overwhelming problem”). The PDI
exhibits good reliability and validity (Cronbach’s coef-
ficient alpha = 0.93), and the test-retest reliability was
also good (r = 0.85) [44]. A French version has been trans-
lated by Gagnon [18] and validated by Chochinov and his
team [45].
Post-traumatic growth
The Posttraumatic Growth Inventory (PTGI) [46] will be
used in our study to describe the change experienced by
the patient since his or her cancer diagnosis. It consists
of 21 declarative statements, with responses ranking
from 0 to 5 (0 = “I did not experience this change”; 5 = “I
experienced this change to a great extent”). The PTGI
determines five factors: appreciation of life, relating to
others, personal strengths, new possibilities, and spiritual
change. The PTGI exhibits good internal consistency
(Cronbach’s alpha coefficient = 0.90), and an acceptable
test-retest reliability (r = 0.71) [47]. This instrument has
been translated and validated into French (Cronbach’s
alpha coefficient = 0.88 and the reliability = 0.47 for the
French version) [48, 49].
Satisfaction with life
The Satisfaction with Life Scale (SWLS) [50] is used
to evaluate patients’ satisfaction with life as a whole.
It assesses a given individual’s global assessment of
life satisfaction, and hence allows respondents to
weight domains of their lives in terms of their own
values. The SWLS contains five items and uses a
scale of 1–7 (1 = “strongly disagree” and 7 = “strongly
agree”). Cronbach’s alpha coefficient is between 0.79
and 0.89, and reliability is r = 0.84 [51]. The instru-
ment has been translated into French and Cronbach’s
alpha coefficient is between 0.80 and 0.84 for the
French version [52]. Reliability and validity indices
were validated and compared with those of the
original English version.
Acceptability questionnaires
The acceptability questionnaire was developed by the
research team based on the literature and will be
addressed to participants at T2. It uses a scale of 1–5
(1 = “strongly disagree” and 5 = “strongly agree”) to as-
sess five items: (1) the topics discussed during the
interview (facility of understanding, if the questions
are intrusive, distressing, relevant), (2) the planning of the
meetings (the number and spacing), (3) the environment
of the intervention (comfort and appropriateness), (4) the
booklet (content and presentation), and (5) more gener-
ally, whether the intervention is helpful, the satisfaction of
the intervention and if the participant would recommend
the Revie ⊕ to other patients.
At the end of the study, an acceptability questionnaire
addressed to the nurses delivering the intervention will
be administrated. The questionnaire was developed by
the research team based on the literature. It uses a scale
of 1–5 (1 = “strongly disagree” and 5 = “strongly agree”)
to assess the same five items as the participants as well
as the monitoring protocol, and the training, supervision
and debriefing.
Intervention fidelity
To obtain fidelity, a guide for conducting the inter-
vention was created. The nurses keep the guide
during the intervention. During training, the import-
ance of adhering to this guide was emphasized. The
interviews are tape-recorded. Subsequently, the re-
search team listens to the tapes to create the booklet.
If case deviations are perceived, the researcher asks
the nurses to adjust their intervention delivery. Regu-
lar meetings between researcher and nurses are
planned in which nurses can also express their feel-
ings and views. Finally, the nurses keep a personal
diary and can add comments regarding difficulties or
barriers to maintain intervention fidelity. At the end
of the empirical phase, the diaries will be analyzed.
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Qualitative part
At the end of the intervention and after completing the
post-test questionnaires (T2), a semi-structured inter-
view will be conducted by the researcher, which lasts for
about 30 min. This interview focuses on the experience
of the intervention and the process.
The following questions are addressed: “You shared
your life perspectives and finalized a booklet. What do
you think and feel about the whole experience and the
process? What feelings did you experience most in-
tensely during the process?”
The nurses are also invited to keep a notebook in
which they can note their difficulties and their emotions.
These writings will be transcribed and a thematic ana-
lysis will be performed. To gather more detail about
their intervention experience, a focus group will be led
by two facilitators who are external to the research.
Data analysis
The protocol is drafted in accordance with the SPIRIT
2013 statement [53].
Quantitative part
Data analysis will be performed using Stata Software
Stata©. Descriptive statistics (mean, median, standard
deviation) will be calculated for sociodemographic data.
Analyses will be carried out on all available patient data
with data at baseline and at the end of the study inter-
vention. We will report descriptive findings concerning
recruitment numbers, completions, drop-out rates, and
missing data. Quantitative data will be cleaned, i.e.,
checked for out of range values and missing values. For
>10 % of missing values, the subject will not be consid-
ered. Distribution of variables will be checked for
normality using box plot, skewness and kurtosis, and
test of normality. The data will be summarized with
standard descriptive measurements. Continuous vari-
ables will be summarized by their mean and standard
deviation, categorical variables as numbers and percent-
ages, and presented with 95 % confidence intervals.
Qualitative data
Qualitative data will be managed using MAXQDA
software.
The interviews will be transcribed and an inductive
thematic analysis will be performed [54]. At least two
researchers will independently code the interviews [55].
Reliability will be analyzed by comparing coding among
coders, and an intercoder agreement will be checked within
the research team. The codes will be assigned into themes.
Using an embedded concurrent design allows qualita-
tive data to complement quantitative data, thus giving a
more comprehensive perspective on the phenomenon of
the study [37]. This study will also provide data to
contribute to sample size calculations for a future larger
effectiveness trial.
Ethics, consent, and permissions
Our study protocol was approved by the Cantonal
Commission of Ethics of Scientific Research (reference
no. 15-037; see Additional files 1, 2, and 3). All patients
in the study will provide written informed consent for
study inclusion and the publication of data (albeit an-
onymously). Given the sensitivity of the topic investi-
gated, there is a minimal risk of disrupting the
psychological and emotional comfort of the participant.
Nurses who conduct the intervention have professional
experience and are specialized in oncology or palliative
care. This enables them to provide psychological support
during and after the intervention. In the case of severe
emotional reaction, an internal resource for psychological
support will be offered.
Data management
The information collected will be treated anonymously
and confidentially. All collected information will be
encrypted through an identification number (the partici-
pant’s name will not appear). Data will be stored in a
computer database to which access will be protected by
passwords known only to the investigators. Personal data
can be made available confidentially for audit or inspec-
tion by authorities, and in order to verify the application
of ethical principles of good clinical practice in the
context of a research protocol. After the transmission of
data and analysis, it will become impossible to identify
patients in any published articles. All documents related
to the research will be archived for 10 years.
Measures to protect the confidentiality of the research
data (i.e., privacy, coding, and storage) are included in
this study, and as the risk level for participants is low, a
data monitoring committee (DMC) was not deemed ne-
cessary for this feasibility study.
Discussion
This new LRI intervention, called Revie ⊕, intends to
promote the dignity of patients with advanced stage
cancer. This study is innovative because there is a
paucity of knowledge and information regarding life
review interventions focusing on a positive, person-
centered approach in palliative care and how this may
apply under current cancer care settings in Switzerland.
Life review interventions have already proven to be ef-
fective in other countries, such as Canada, Australia,
and Asia. It can be expected, therefore, that this study
will provide new data that may be of specific relevance
to the setting in Switzerland.
This preliminary study should inform about the
recruitment process and the adherence and retention of
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this particularly vulnerable population. It aims to give in-
dications about the feasibility of this innovative interven-
tion and, eventually, how to adapt the content and
duration of the intervention. We will obtain information
about the helpfulness of the approach by patient ques-
tionnaires and interviews. In addition, the perspective of
the nurses about the acceptability of this intervention
will be elicited. Nurses will be asked to provide their
views about this intimate and sensitive intervention.
The use of an embedded design is recommended for
testing complex patient-centered interventions, particu-
larly for pilot studies in which new areas are investi-
gated. We will obtain information about the sampling,
the intervention delivery, study implementation, and
study outcomes and measures [56].
The data will help us to validate the instruments used
and determine the required sample size. If the findings
from our pilot study suggest that the trial is feasible, a
future larger study will be planned to measure the effect-
iveness of this complex intervention. This study aims
also to measure strength and promote patient dignity,
rather than focusing on the problems or difficulties that
patients may face. Steering the intervention towards a
positive approach, that is to say the positive changes that
can occur as the direct result of experiencing a cancer
diagnosis, could contribute to personal development and
a better overall level of satisfaction with life. Being more
in tune with the values and preferences of afflicted indi-
viduals could substantially contribute to their well-being
in the final stages of their lives.
Study status
The study began in April 2015. To date, 30 participants
have been recruited and 27 interventions have been per-
formed (three interventions have yet to be delivered).
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